Adding amikacin to fluoroquinolone-based antimicrobial prophylaxis reduces prostate biopsy infection rates.
Batura
Deepak
D
Departments of Urology and *Microbiology, Northwick Park Hospital, London, and †Statistics, Modelling and Bioinformatics Department, Centre of Infections, Health Protection Agency, UK.
Rao
G Gopal
GG
Departments of Urology and *Microbiology, Northwick Park Hospital, London, and †Statistics, Modelling and Bioinformatics Department, Centre of Infections, Health Protection Agency, UK.
Bo Nielsen
Peder
P
Departments of Urology and *Microbiology, Northwick Park Hospital, London, and †Statistics, Modelling and Bioinformatics Department, Centre of Infections, Health Protection Agency, UK.
Charlett
André
A
Departments of Urology and *Microbiology, Northwick Park Hospital, London, and †Statistics, Modelling and Bioinformatics Department, Centre of Infections, Health Protection Agency, UK.
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000583:Amikacin / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D019072:Antibiotic Prophylaxis / Q000379:methods; D016470:Bacteremia / Q000517:prevention & control; D001424:Bacterial Infections / Q000517:prevention & control*; D001707:Biopsy, Needle / Q000009:adverse effects*; D016009:Chi-Square Distribution; D004359:Drug Therapy, Combination; D024841:Fluoroquinolones / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000382:microbiology; D011467:Prostate / Q000473:pathology; D011469:Prostatic Diseases / Q000517:prevention & control*; D016896:Treatment Outcome; D014552:Urinary Tract Infections / Q000517:prevention & control
D000900:Anti-Bacterial Agents; D024841:Fluoroquinolones; D000583:Amikacin